Fluzoparib and Apatinib Versus Fluzoparib in Relapsed Ovarian Carcinoma Maintenance Treatment
Clinical trial NCT05479487 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05479487
- Sponsor
- Xiaohua Wu MD
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-01
- Primary completion
- 2023-11-01
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.